235 related articles for article (PubMed ID: 36349861)
1. The renin-angiotensin-aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC.
Yazdani B; Delgado GE; Kleber ME; Yücel G; Husain-Syed F; Kraemer TD; Jochims J; Leipe J; März W; Krämer BK
J Clin Hypertens (Greenwich); 2022 Dec; 24(12):1587-1597. PubMed ID: 36349861
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
[TBL] [Abstract][Full Text] [Related]
3. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
[TBL] [Abstract][Full Text] [Related]
4. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
Werner C; Pöss J; Böhm M
Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
Adin D; Atkins C; Domenig O; DeFrancesco T; Keene B; Tou S; Stern JA; Meurs KM
J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
[TBL] [Abstract][Full Text] [Related]
6. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
7. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
Lee AF; MacFadyen RJ; Struthers AD
Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients.
van Vark LC; Bertrand M; Akkerhuis KM; Brugts JJ; Fox K; Mourad JJ; Boersma E
Eur Heart J; 2012 Aug; 33(16):2088-97. PubMed ID: 22511654
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
10. Arterial stiffness and the renin-angiotensin-aldosterone system.
Mahmud A; Feely J
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):102-8. PubMed ID: 15526244
[TBL] [Abstract][Full Text] [Related]
11. Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.
Loader J; Taylor FC; Lampa E; Sundström J
J Am Heart Assoc; 2022 Jun; 11(11):e025289. PubMed ID: 35624081
[TBL] [Abstract][Full Text] [Related]
12. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
Schjoedt KJ; Jacobsen P; Rossing K; Boomsma F; Parving HH
Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104
[TBL] [Abstract][Full Text] [Related]
13. The Renin-Angiotensin-Aldosterone System in Smokers and Non-Smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Delgado GE; Siekmeier R; Krämer BK; Grübler M; Tomaschitz A; März W; Kleber ME
Adv Exp Med Biol; 2016; 935():75-82. PubMed ID: 27334735
[TBL] [Abstract][Full Text] [Related]
14. Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.
Ferrario CM
Life Sci; 2010 Feb; 86(9-10):289-99. PubMed ID: 19958778
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.
Mercier K; Smith H; Biederman J
Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533
[TBL] [Abstract][Full Text] [Related]
16. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.
Koumaras C; Tziomalos K; Stavrinou E; Katsiki N; Athyros VG; Mikhailidis DP; Karagiannis A
J Am Soc Hypertens; 2014 Feb; 8(2):74-82. PubMed ID: 24139833
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin-aldosterone-system inhibitors on coronary atherosclerotic plaques: The PARADIGM registry.
Williams C; Han D; Takagi H; Fordyce CB; Sellers S; Blanke P; Lin FY; Shaw LJ; Lee SE; Andreini D; Al-Mallah MH; Budoff MJ; Cademartiri F; Chinnaiyan K; Choi JH; Conte E; Marques H; de Araújo Gonçalves P; Gottlieb I; Hadamitzky M; Maffei E; Pontone G; Shin S; Kim YJ; Lee BK; Chun EJ; Sung JM; Virmani R; Samady H; Stone PH; Berman DS; Narula J; Bax JJ; Leipsic JA; Chang HJ
Atherosclerosis; 2023 Oct; 383():117301. PubMed ID: 37769454
[TBL] [Abstract][Full Text] [Related]
18. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
19. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
20. Effects of Renin-Angiotensin-Aldosterone System Inhibition on Left Ventricular Hypertrophy, Diastolic Function, and Functional Status in Patients With Hypertrophic Cardiomyopathy: A Systematic Review.
Akhtar H; Al Sudani H; Hussein M; Farhan MUN; Elkholy K
Cureus; 2022 Jul; 14(7):e26642. PubMed ID: 35949750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
